aiwiki.page
English
Health / Diseases & Symptoms / acanthosis-nigricans

Acanthosis Nigricans

Acanthosis nigricans is a skin condition causing darkened, thickened, velvety patches, most often in body folds and commonly associated with insulin resistance.

14 keywords1 linked from1 not yet writtenWritten by AI
Insulin Resistan…ObesityInsulinPrediabetesType 2 DiabetesCorticosteroidCancerDiagnosisAcanthosis…

Acanthosis nigricans is a skin condition characterized by poorly defined areas of darkened, thickened skin with a velvety surface, usually affecting body folds. It is most commonly associated with insulin resistance and obesity, but can also occur with certain inherited conditions, medications, and, rarely, an internal malignancy. It is not contagious and does not result from inadequate hygiene.

Clinical features

Typical sites include the back and sides of the neck, armpits, and groin. Changes are usually symmetrical and develop gradually. The knuckles, elbows, knees, and other areas may also be affected. Color ranges from light brown to gray-brown or nearly black, depending partly on baseline skin pigmentation. Increased thickness and altered texture can be more conspicuous than color change.

The skin may become ridged or develop small, projecting elevations. Skin tags can occur in the same areas. Most lesions cause few symptoms, although itching sometimes occurs. Oral mucosal involvement and extensive, rapidly developing lesions are less typical of the common metabolic form.

Causes and biological mechanisms

Metabolic associations

The most frequent setting is insulin resistance, in which tissues respond less effectively to insulin. Compensatory increases in circulating insulin are thought to stimulate growth-related signaling in skin cells, contributing to epidermal thickening and the characteristic surface texture.

Acanthosis nigricans can accompany prediabetes or type 2 diabetes, but its presence does not establish either diagnosis. Conversely, many people with insulin resistance do not develop it. It can also occur in polycystic ovary syndrome, particularly when insulin resistance is present.

Inherited and medication-associated forms

Some cases begin in childhood and occur in families. Rare genetic syndromes can include acanthosis nigricans alongside other abnormalities, including severe insulin resistance.

Medication-associated cases have been reported with agents such as systemic corticosteroids and high-dose niacin. More than one contributing factor may be present, so an association with medication does not necessarily establish that medication as the sole cause.

Malignancy-associated form

Malignant acanthosis nigricans is a rare form associated with an internal malignancy, classically gastric adenocarcinoma. The skin lesions themselves are not cancerous; they represent a response to processes occurring elsewhere in the body.

This form may begin abruptly, progress rapidly, become widespread, or involve mucous membranes. Markedly thickened palms with exaggerated skin markings, termed tripe palms, may coexist. Tumor-derived growth factors are thought to contribute. These features are not individually diagnostic of cancer, and most cases of acanthosis nigricans are not malignancy-associated.

Diagnosis and differential diagnosis

Diagnosis is usually clinical, based on the distribution, texture, and appearance of the skin changes. Medical history and physical examination help establish the likely context, including onset, progression, medication exposure, and associated findings.

When the appearance is uncertain, a skin biopsy can demonstrate hyperkeratosis and papillomatosis—thickening of the outer keratin layer and an undulating or projecting epidermal surface. Despite the condition’s name, true acanthosis, meaning thickening of the epidermal spinous layer, may be relatively mild.

The differential diagnosis includes confluent and reticulated papillomatosis, friction-related pigmentation, post-inflammatory hyperpigmentation, erythrasma, and some superficial fungal conditions. These disorders differ in their texture, distribution, accompanying findings, or test results.

Investigations for associated disease depend on the clinical setting. Glucose-related testing, including glycated hemoglobin, may identify abnormalities of glucose regulation. The skin findings alone neither measure the severity of insulin resistance nor determine the need for a particular cancer investigation.

Management and course

Management is directed primarily at the associated condition when one is identified. Skin changes may lessen when metabolic abnormalities improve, a causative medication is withdrawn, or an associated malignancy is treated, but resolution is variable and may be incomplete.

Topical retinoids and keratolytic preparations have been used to reduce thickness and improve appearance. Evidence for skin-directed treatments is limited, and improvement may be temporary. The course depends on the underlying cause rather than on pigmentation alone.